Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

17:43 EDT 28th April 2017 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

FDA OKs Medtronic's New Kyphon Xpede Bone Cement

  Life Sciences Jobs   ...

Medtronic secures extended FDA indication for bone cement

Medtronic has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Kyphon Xpede bone cement to treat sacral fractures.

Carestream Health Release: Company???s Successful R&D Efforts Earn 43 U.S. Patents During 2016; 52 Additional Patents In Other Countries

  Life Sciences Jobs   ...

NIH funding helps generate private-sector patents

Research grants issued by the National Institutes of Health (NIH) contribute to a significant number of private-sector patents in biomedicine, according to a new study. The study examines 27 years of ...

Pharma Patents Are Vulnerable In Canada As Lilly Loses NAFTA Challenge

Tribunal finds Lilly did not prove that Canada's promise utility doctrine discriminates against pharmaceutical patents; 25 pharma patents have been...   

Medtronic's sacral fracture-treating bone cement cleared by FDA

Kyphon Xpede Bone Cement, developed by Medtronic for treating sacral fractures, has been granted 510(k) clearance by the FDA. -More- 

joimax Release: Company Shows Strong Growth Trend Again In 2016 And Is Issued New Patents, The Company Now Holds Than 150 Patents And Trademarks Worldwide

  Life Sciences Jobs   ...

Gilead ordered to pay $2.54 billion to Merck over hepatitis C patents

The verdict is the latest twist in a heated battle between the two drug giants over hepatitis C patents, which have proven to be extremely lucrative.

Matching PubMed Articles

Effect of the economic crisis on the production of immunology patents managed through the Patent Cooperation Treaty agreement from 2004-2011.

To determine the evolution of patents in immunology, as a result of research and innovation in the years 2004-2011.

Tracing Technological Development Trajectories: A Genetic Knowledge Persistence-Based Main Path Approach.

The aim of this paper is to propose a new method to identify main paths in a technological domain using patent citations. Previous approaches for using main path analysis have greatly improved our und...

HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).

Statins are remarkably safe and efficient medications that are the mainstay of hypercholesterolemia treatment and have proven to be an invaluable tool to lower the risk of acute cardiovascular events....

Are sigma modulators an effective opportunity for cancer treatment? a patent overview (1996-2016).

Although several molecular targets against cancer have been identified, there is a continuous need for new therapeutic strategies. Sigma Receptors (SRs) overexpression has been recently associated to ...

Compulsory licensing of patents in India.

This article deals with compulsory licensing scenarios in India, provides a background of relevant provisions in the Patents Act and examines how these provisions are Trade-Related Aspects of Intellec...

Search Whole site using Google

Quick Search
Advertisement Advertisement